Study: MDLinx Catapults to #1 Website for U.S. Oncologists

June 7, 2011

Leads all other sites with an average of more than 10 visits per month

Washington, DC, June 7, 2011 – MDLinx today announced that a prominent third party study of oncologists’ internet use revealed the popular physician web site to be the leading online resource for US oncologists, with 46 percent of U.S. oncologists visiting an average of more than 10 times per month.

“We’ve actually seen even faster growth of our oncology membership since the study was published,” said Stephen Smith, Chief Marketing Officer for MDLinx. “Today more than 70% of U.S. oncologists use MDLinx. We are seeing rapid growth in every specialty, with 10% increase in site traffic every month. We seem to have reached the tipping point where physicians hear enough about a source from their colleagues that they feel they have to be in the loop,” Smith explained. Smith said the study results validate MDLinx’s strategic decision to lead with oncology in their plans to capture a significant portion of online physician time. “These results prove the compelling value of MDLinx for busy physicians,” said Smith. “In the last 12 months we have expanded our strategic focus to include several other specialties, and we are seeing growth patterns similar to what this study found for oncologists.”

The study, published in Oncology Business Review, was based on a tracking survey by the research firm ImpactRX from a group of 475 oncologists followed for a nine-month period during 2010. “MDLinx was the number one site in terms of oncologist visits per month. The results were striking in that MDLinx was the only site to rank as number one or number two in every category measured by the study,” said Smith.

“Oncologists drowning in data, starved for wisdom”

Smith explained the success in oncology and similar growth in other specialties was caused by the confluence of several drivers. “The growing urgency for solutions to the medical information overload, our focus on continually releasing new products and improved products to meet the need, and a tipping point in industry recognition as an industry source are the factors we are seeing now,” said Smith. “With hundreds of significant papers published each day, doctors are often &lsqou;drowning in data and starved for wisdom’,” Smith said. “We are trying to solve that problem for physicians.”

About MDLinx
MDLinx is an award-winning, practical medical information tool used by busy physicians and healthcare professionals to stay up to date with the latest research in the medical field. On a daily basis, the company’s physician editors read, rank and sort published data and research from leading news media and more than 1,300 peer-reviewed journals in 35 specialties. MDLinx’s content and services are provided at no charge to member physicians. MDLinx is a web property of M3 USA, which offers information solutions to healthcare providers and marketing solutions to the pharmaceutical industry.

Greg Jones for MDLinx